Our results indicated that ATRX was upregulated via DNA demethylation mediated by STAT5b/TET2 complex in TMZ resistant glioma cells and that ATRX promoted PARP1 stabilization through down-regulating FADD by suppressing of H3K27me3 enrichment in FADD promoter region. The gene discussed is TET2; the disease is central nervous system cancer.